Abstract
The advance in nanotechnology (NDDS) which helps in preparing newer formulations.One of the advancement in nanotechnology is the preparation of ‘Proniosome derived’ niosomes. Approaches to stabilize niosomal drug delivery system without affecting its properties of merits have resulted in the development of the promising drug carrier, proniosome.These proniosomes minimize or reduces problems of niosomes associated with physical stability such as aggregation,fusion,leakage problems and provide additional convenience intransportation, distribution, storage and dosing.The review article provides an insight about these approaches along with a novel vesicular approach known as proniosomes. This new emerging concept has demonstrated the potential in improving the oral bioavailability, targeting drugs to the specific target site and also permeation of drugs across the stratum corneum(skin). It prolongs the existence of the drug in systemic circulation(blood circulation) and finally reduces the toxicity. The goal of this study is to introduce and explore proniosomes as a carrier system for various pharmaceutical and cosmeceutical applications.
References
Abd-Elbary, H.M. El-laithy , M.I. Tadros Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium International Journal of Pharmaceutics 357 (2008) 189–198.
Akhilesh D, Faishal G, Prabhu P. Development and Optimization of Proniosomes for Oral delivery of Glipizide. Int J Pharm Pharm Sci, 4(3), 2012, 307-314.
Almira I, Blazek-Welsh, Rhodes DG. Maltodextrin- Based Proniosomes. AAPS PharmSciTech 3 (1) article 1.2001.
Alsara IA, Bosela AA, Ahmed SM. Proniosomes as a drug carrier for transdermal delivery of Ketorolac. European Journal of Pharmaceutics and Biopharmaceutics, 59, 2005, 485-490.
D Akhilesh, G Faishal, JV Kamath. Comparative Study of Carriers used in Proniosomes, Int.J Pharm Chem Sci 2012; 1(1): 164-173.
Goud BA, Jukanti R, Rambahu D. Improved Oral Absorption of Carbamazepine from Sorbitan Monolaurate based Proniosome Systems containing Charged Surface Ligands. International Journal of Biological and Pharmaceutical Research, 3(1), 2012, 37-42.
Gupta A, Prajapati SK, Balamurugan M, Singh M. Design and Development of a Proniosomal Transdermal Drug Delivery system for Captopril. Tropical Journal of Pharmaceutical Sciences, 6(2), 2007, 687-693.
Hanan M, Omar S. Novel sugar esters proniosomes for transdermal delivery of Vinpocetine: Preclinial and clinical studies. European Journal of Pharmaceutics and Biopharmaceutics, 77, 2011, 43-55.
Ijeoma F, Uchegbu, Suresh P. Vyas, Non-ionic surfactant based vesicles (niosomes) in drug delivery, Int. J. Pharm., 172, 1998, 33-70.
Kishore N. Proniosome Gel: Potential Carrier System in Topical/Transdermal Delivery for Drugs and Cosmetics/Cosmecueticals. 2010. [cited 2010 May 31]. Available from: URL: http://www.pharmainfo.net
Kumar K, Rai AK. Development and Evaluation of Proniosomes as a promising drug carrier to improve transdermal drug delivery. IRJP, 2(11), 2011, 71-74.
Kumar S, et al, Site directed drug delivery bynon-viral mode, Indian Journal of Biotechnology. 6, 2007, 159- 174.
N Pandey. Proniosomes and Ethosomes: New Prospect in Transdermal and Dermal Drug Delivery System. IJPSR 2011; 2(8): 1988-1996.
Prakash SG, Joshi VG. An engineered specificity of Irinotecan loaded Proniosomes: Design and Characterization. International Journal of Drug Delivery, 3, 2011, 472-480.
Rao R, Kakar R, Anju G, Sanju N. Proniosomes: An Emerging Vesicular System in Drug Delivery and Cosmetics. Der Pharmacia Lettre, 2(4), 2010, 227-239.
Ruckmani K, Sankar V, Durga S, Jailani S. Proniosomes as Drug Carriers. Pak. J. Pharm. Sci, 23(1), 2010, 103- 107.
Schereie H, Bouwstra J, Liposomes and niosomes as topical drug carriers- dermal and transdermal drug delivery, J. Control. Release, 30, 1994, 1-15.
Solanki AB, Parikh JR and Parikh RH. Formulation and optimization of Piroxicam proniosomes by 3-Factor, 3- Level Box-Behnken Design. AAPS Pharm. Sci. Tech., 8(4):2007
Srivastava AR, Uresekar B, Kapadia CJ. “Design, optimization, preparation and evaluation of dispersion granules of valsartan and formulation into tablets.” Curr Drug Delivery, 6:2009, 28-37
Sudhamani T, Priyadarisini N, Radhakrishan M. Proniosomes– A Promising Drug Carrier. Int.J. Pharm Tech Res, 2(2), 2010, 1446-1454.
Thakur R, Anwer MK, Shams MS, Ali A, Khar RK, Shakeel F, Taha EI. Proniosomal transdermal therapeutic system of losartanpotassium: development and pharmacokinetic evaluation J Drug Target. 17(6):2009, 442-9.
Thejaswi C, Gobinath M and Radharni J. A review on design and characterization of Proniosomes As a drug carrier,Dept.of Pharmaceutics,Ratnam Institute of pharmacy, Nellore.
Thejaswi C, Rao M, Gobinath M, Radharani J, Hemafaith V, Venugopalaiah P, A review on design and characterization of proniosomes as a drug carrier, IJAPN,1, 2011, 16-19.
Varshosaz J, Pardakhty A, Baharanchi SM. Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate. Drug Delivery 12(2):2005, 75-82.
Vora B, Khopade AJ and Jain NK Proniosome based transdermal delivery of levonorgesterel for effective contraception. J. Control. Rel., 54:1998 149-165.
Yadav K, Yadav D, Saroha K, Nanda S, Mathur P. Proniosomal Gel: A provesicular approach for transdermal drug delivery. Der Pharmacia Lettre, 2(4), 2010, 189-198.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array